Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.

Wu S, Lin SX, Lu M, Subtelny AO, Wang Z, Dahl DM, Olumi AF, Wu CL.

Int Urol Nephrol. 2019 Jun 10. doi: 10.1007/s11255-019-02181-7. [Epub ahead of print]

PMID:
31183659
2.

MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER.

Hanna N, Wszolek MF, Mojtahed A, Nicaise E, Wu B, Gelpi-Hammerschmidt FJ, Salari K, Dahl DM, Blute ML, Harisinghani M, Feldman AS.

J Urol. 2019 May 30:101097JU0000000000000359. doi: 10.1097/JU.0000000000000359. [Epub ahead of print]

PMID:
31144593
3.

Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years.

Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS.

J Urol. 2019 Apr;201(4):721-727. doi: 10.1097/JU.0000000000000031.

PMID:
30664083
4.

Case 36-2018: A 29-Year-Old Man with an Incidentally Discovered Renal Mass.

Dahl DM, Simeone JF, Iliopoulos O, Saylor PJ, Wu CL.

N Engl J Med. 2018 Nov 22;379(21):2064-2072. doi: 10.1056/NEJMcpc1802832. No abstract available.

PMID:
30462933
5.

Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.

Wu S, Lin SX, Wirth GJ, Lu M, Lu J, Subtelny AO, Wang Z, Dahl DM, Olumi AF, Wu CL.

Clin Genitourin Cancer. 2019 Feb;17(1):e44-e52. doi: 10.1016/j.clgc.2018.08.007. Epub 2018 Aug 30.

PMID:
30287224
6.

Case 10-2018: An 84-Year-Old Man with Painless Unilateral Testicular Swelling.

Thompson RW, Yu H, Dahl DM, Hurtado RM, Sajed DP.

N Engl J Med. 2018 Mar 29;378(13):1233-1240. doi: 10.1056/NEJMcpc1712224. No abstract available.

PMID:
29590543
7.

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.

Miyamoto DT, Lee RJ, Kalinich M, LiCausi JA, Zheng Y, Chen T, Milner JD, Emmons E, Ho U, Broderick K, Silva E, Javaid S, Kwan TT, Hong X, Dahl DM, McGovern FJ, Efstathiou JA, Smith MR, Sequist LV, Kapur R, Wu CL, Stott SL, Ting DT, Giobbie-Hurder A, Toner M, Maheswaran S, Haber DA.

Cancer Discov. 2018 Mar;8(3):288-303. doi: 10.1158/2159-8290.CD-16-1406. Epub 2018 Jan 4.

8.

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.

Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA.

J Urol. 2018 Feb;199(2):407-415. doi: 10.1016/j.juro.2017.08.106. Epub 2017 Sep 1.

PMID:
28870862
9.

Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.

Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. [Epub ahead of print]

PMID:
28864223
10.

Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals.

Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, Frank I, Carlson RE, Rangel LJ, Barry MJ, Blute ML, Karnes RJ.

Eur Urol Focus. 2016 Jun;2(2):172-179. doi: 10.1016/j.euf.2015.06.011. Epub 2015 Jul 15.

PMID:
28723533
11.

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).

Michaelson MD, Hu C, Pham HT, Dahl DM, Lee-Wu C, Swanson GP, Vuky J, Lee RJ, Souhami L, Chang B, George A, Sandler H, Shipley W.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):995-1001. doi: 10.1016/j.ijrobp.2016.12.018. Epub 2016 Dec 19.

12.

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA.

Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.

PMID:
28081860
13.

Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.

Mao Y, Kilcoyne A, Hedgire S, Preston MA, McGovern FJ, Dahl DM, Harisinghani M.

AJR Am J Roentgenol. 2016 Oct;207(4):789-796. doi: 10.2214/AJR.16.16064. Epub 2016 Jul 6.

PMID:
27382922
14.

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.

Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA.

J Clin Oncol. 2016 Aug 10;34(23):2705-11. doi: 10.1200/JCO.2016.66.7527. Epub 2016 Jun 13.

15.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 May;14(5):509-19.

PMID:
27160230
16.

NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.

PMID:
26656522
17.

Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma.

Huang J, Dahl DM, Dong L, Liu Q, Cornejo K, Wang Q, Wu S, Feldman AS, Huang Y, Xue W, Wu CL.

Biomed Res Int. 2015;2015:891045. doi: 10.1155/2015/891045. Epub 2015 Sep 3.

18.

RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.

Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, Arora KS, Desai N, Dahl DM, Sequist LV, Smith MR, Kapur R, Wu CL, Shioda T, Ramaswamy S, Ting DT, Toner M, Maheswaran S, Haber DA.

Science. 2015 Sep 18;349(6254):1351-6. doi: 10.1126/science.aab0917.

19.

Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.

Preston MA, Feldman AS, Coen JJ, McDougal WS, Smith MR, Paly JJ, Carrasquillo R, Wu CL, Dahl DM, Barrisford GW, Blute ML, Zietman AI.

Urol Oncol. 2015 Sep;33(9):383.e9-16. doi: 10.1016/j.urolonc.2015.04.015. Epub 2015 Jun 6.

PMID:
26059076
20.

Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.

Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, Dahl DM, Wu S, Blute ML, Huang Y, Wu CL.

Clin Genitourin Cancer. 2015 Oct;13(5):e353-60. doi: 10.1016/j.clgc.2015.04.014. Epub 2015 May 4.

PMID:
25998556
21.

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219.

PMID:
25190691
22.

Diversion ahead: imaging appearance of urinary diversions and reservoirs.

Hedgire SS, Tabatabaei S, McDermott S, Feldman A, Dahl DM, Harisinghani MG.

Clin Imaging. 2014 Jul-Aug;38(4):418-427. doi: 10.1016/j.clinimag.2014.01.017. Epub 2014 Feb 7. Review.

PMID:
24602415
23.

Prognostic significance of indeterminate lung nodules in renal cell carcinoma.

Xu R, Horick N, McGovern FJ, Dahl DM, Feldman AS, Blute ML, Olumi AF, Michaelson MD.

Urol Oncol. 2014 Apr;32(3):355-61. doi: 10.1016/j.urolonc.2013.09.001. Epub 2014 Jan 4.

PMID:
24397994
24.

Midterm oncological outcomes of laparoscopic vs open radical prostatectomy (RP).

Wirth GJ, Psutka SP, Chapin BF, Wu S, Wu CL, Dahl DM.

BJU Int. 2013 Jul;112(2):190-7. doi: 10.1111/bju.12085. Epub 2013 Apr 19.

25.

A close surgical margin after radical prostatectomy is an independent predictor of recurrence.

Lu J, Wirth GJ, Wu S, Chen J, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL.

J Urol. 2012 Jul;188(1):91-7. doi: 10.1016/j.juro.2012.02.2565. Epub 2012 May 12.

PMID:
22578729
26.

Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level.

Kaufman DS, Zietman AL, McDougal WS, Dahl DM, Harisinghani MG, Wu CL.

N Engl J Med. 2012 Mar 22;366(12):1143-50. doi: 10.1056/NEJMcpc1104320. No abstract available.

PMID:
22435374
27.

Smaller prostate gland size and older age predict Gleason score upgrading.

Gershman B, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL.

Urol Oncol. 2013 Oct;31(7):1033-7. doi: 10.1016/j.urolonc.2011.11.032. Epub 2011 Dec 28.

PMID:
22206627
28.

Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know.

Tabatabaei S, Saylor PJ, Coen J, Dahl DM.

AJR Am J Roentgenol. 2011 Jun;196(6):1263-6. doi: 10.2214/AJR.10.6263. Review.

PMID:
21606287
29.

Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.

Kaufman DS, Zietman AL, Dahl DM, Harisinghani MG, Wu CL.

N Engl J Med. 2011 Feb 17;364(7):667-75. doi: 10.1056/NEJMcpc1005310. No abstract available.

PMID:
21323545
30.

Editorial comment.

Dahl DM.

Urology. 2011 Jan;77(1):136. doi: 10.1016/j.urology.2010.04.061. No abstract available.

PMID:
21195833
31.

Case records of the Massachusetts General Hospital. Case 23-2010. A 49-year-old man with erythrocytosis, perinephric fluid collections, and renal failure.

Bazari H, Attar EC, Dahl DM, Uppot RN, Colvin RB.

N Engl J Med. 2010 Jul 29;363(5):463-75. doi: 10.1056/NEJMcpc1004086. No abstract available.

PMID:
20818867
32.

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.

Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S.

Sci Transl Med. 2010 Mar 31;2(25):25ra23. doi: 10.1126/scitranslmed.3000403.

33.

Commentary.

Dahl DM.

J Am Coll Surg. 2009 Sep;209(3):376-7. doi: 10.1016/j.jamcollsurg.2009.06.366. No abstract available.

PMID:
19717043
34.

Editorial comment.

Dahl DM, Ko DS.

Urology. 2009 Sep;74(3):687. doi: 10.1016/j.urology.2009.04.054. No abstract available.

PMID:
19716928
35.

A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy.

Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS.

J Urol. 2009 Sep;182(3):956-65. doi: 10.1016/j.juro.2009.05.044. Epub 2009 Jul 17.

PMID:
19616252
36.

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.

Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.

Clin Imaging. 2009 Jul-Aug;33(4):301-5. doi: 10.1016/j.clinimag.2009.01.013.

PMID:
19559353
37.

Chyluria secondary to lymphorenal fistula.

Eisner BH, Tanrikut C, Dahl DM.

Kidney Int. 2009 Jul;76(1):126. doi: 10.1038/ki.2009.64. No abstract available.

38.

The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL.

BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.

39.

Impact of preoperative endorectal MRI stage classification on neurovascular bundle sparing aggressiveness and the radical prostatectomy positive margin rate.

Brown JA, Rodin DM, Harisinghani M, Dahl DM.

Urol Oncol. 2009 Mar-Apr;27(2):174-9. doi: 10.1016/j.urolonc.2008.04.009. Epub 2008 Jul 21.

PMID:
18640062
40.

Management of complications of prostate cancer treatment.

Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR.

CA Cancer J Clin. 2008 Jul-Aug;58(4):196-213. doi: 10.3322/CA.2008.0002. Epub 2008 May 23. Review.

41.

Small changes in operative time can yield discrete increases in operating room throughput.

Seim AR, Dahl DM, Sandberg WS.

J Endourol. 2007 Jul;21(7):703-8.

PMID:
17705754
42.

Laparoscopic inguinal hernia repair during laparoscopic radical prostatectomy.

Lee BC, Rodin DM, Shah KK, Dahl DM.

BJU Int. 2007 Mar;99(3):637-9.

43.

Pathologic outcome of laparoscopic and open radical prostatectomy.

Dahl DM, He W, Lazarus R, McDougal WS, Wu CL.

Urology. 2006 Dec;68(6):1253-6. Epub 2006 Dec 4.

PMID:
17141845
44.

New imaging modalities in bladder cancer.

Saksena MA, Dahl DM, Harisinghani MG.

World J Urol. 2006 Nov;24(5):473-80. Review. No abstract available.

PMID:
17102950
45.

Laparoscopic radical prostatectomy in a renal allograft recipient.

Shah KK, Ko DS, Mercer J, Dahl DM.

Urology. 2006 Sep;68(3):672.e5-7. Epub 2006 Sep 18.

PMID:
16979728
46.

Transperitoneal versus extraperitoneal approach to laparoscopic radical prostatectomy: an assessment of 156 cases.

Brown JA, Rodin D, Lee B, Dahl DM.

Urology. 2005 Feb;65(2):320-4. Review.

PMID:
15708046
47.

Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases.

Brown JA, Rodin DM, Lee B, Dahl DM.

J Urol. 2005 Feb;173(2):442-5.

PMID:
15643198
48.
49.

Ventriculoperitoneal shunt externalization during laparoscopic prostatectomy.

Brown JA, Medlock MD, Dahl DM.

Urology. 2004 Jun;63(6):1183-5.

PMID:
15183985

Supplemental Content

Support Center